NCT03568825

Brief Summary

Response Surface Pathway (RSP) design was previously developed for dose-finding studies with one interventional and one response variable, but RSP to higher dimensions is requested. The aim of this study is to introduce and evaluate the RSP design with two interventional and one response variable exemplified by estimating Minimum Efficacy Dose (MED) of Osteopathic Manual Therapy (OMT) in treatment of gastroesophageal reflux disease (GERD).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
Last Updated

June 26, 2018

Status Verified

June 1, 2018

Enrollment Period

7 months

First QC Date

June 13, 2018

Last Update Submit

June 22, 2018

Conditions

Keywords

Two-dimensional randomized response surface pathway designOsteopathic Manual TherapyOMT in treatment of GERDDose-response

Outcome Measures

Primary Outcomes (1)

  • Percent reduction in sum of the five GERD score from baseline.

    The five GERD variables recorded at baseline and one week after the last treatment were degrees of "Heartburn", "Chest pain", "Acid in mouth", "Epigastric pain" and "Thoracic pain", each recorded on a 10 cm VAS. The response variables were percent reduction in sum of the five GERD variables from baseline.

    One week after last OMT

Study Arms (2)

Number of Osteopatic Manual Therapy

EXPERIMENTAL

Intervention: OMT. Osteopatic Manual treatment consisting of Thoracic spine, Diaphragm mobilisation, Traction of the cardia and posture correction.

Procedure: Osteopatic Manual Therapy (OMT)

Interval in days between each OMT

EXPERIMENTAL

Intervention: OMT. The time between each OMT's is calculated by the study design. Each OMT intervantion consists of Thoracic spine and Diaphragm mobilisation, Traction of the cardia and Posture correction.

Procedure: Osteopatic Manual Therapy (OMT)

Interventions

OMT consisting of following interventions; thoracic spine and diaphragm mobilisation, traction of the cardia and posture correction.

Interval in days between each OMTNumber of Osteopatic Manual Therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosed Gastroesophigual Reflux Disease
  • Known effect of anti-reflux medication

You may not qualify if:

  • Hiatus hernia ≥5 cm
  • gastric ulcer
  • cancer
  • uncontrolled bacterial, viral, fungal or parasite infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Stig E Larsen, PhD

    Norwegian Univesity of Life Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: The study is a RSP designed multicenter study with two interventional- and one response variable. The two-interventional variable were Number of OMTs and Interval in days between each treatment. The GERD variables were degrees of Heartburn, Chest pain, Acid in mouth, Epigastric pain and "Thoracic pain". The response variable were percent reduction in sum of the GERD variables from baseline in 4 categories. Each of the two RSP designs consisted of three dose levels. Three GERD patients were allocated to the first design level given six OMT with five days' interval. Based on the results obtained from the first design level, five patients were subsequently included to the second design level. The number of OMT's and interval between each treatment was separately determined. Seven patients were included to the third design level and given number of OMT's and interval between treatments calculated based on results obtained from the second design level.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 13, 2018

First Posted

June 26, 2018

Study Start

September 28, 2016

Primary Completion

April 24, 2017

Study Completion

October 14, 2017

Last Updated

June 26, 2018

Record last verified: 2018-06